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ABSTRACT
Background and Aims: Though, many practitioners prefer conscious sedation (CS), it is unclear
which factors most influence neurological outcome following mechanical thrombectomy under
CS. The aim of this retrospective study is to identify these factors. Methods: After institutional
review board approval, data were collected for the patients >18 years of age who underwent
endovascular treatment of AIS under CS at our comprehensive stroke centre between January
2009 and June 2015. The primary outcome measure was the modified Rankin Scale (mRS) at
discharge. A good outcome was defined as mRS 0–3 and poor outcome as mRS 4–6. Univariate
and logistic regression analysis were performed to identify the independent predictors of poor
outcomes at discharge. A P < 0.05 was considered statistically significant. Results: One hundred
two patients, aged 67 ± 16 years were included. The anterior cerebral circulation was affected
in 88 patients (86%), and the median National Institute of Health Stroke Scale (NIHSS) score
at presentation was 17.5 (range: 1–36). Overall, 21 (21%) patients had good outcome and
81 (79%) had poor outcome. Logistic regression identified the modified treatment in cerebral
ischaemia (mTICI) score [odds ratio (OR): 0.443, confidence interval (CI): 0.244–0.805],
NIHSS score (OR: 1.290, CI: 1.125–1.481) and previous transient ischaemic attack (TIA) (OR:
6.988, CI: 1.342–36.380) as significant independent predictors of poor outcome at discharge.
Conclusion: The outcome of patients who underwent endovascular treatment of AIS under CS
depends on the mTICI score, NIHSS score and history of previous TIA.
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INTRODUCTION
Acute ischaemic stroke (AIS) is one of the leading
causes of mortality and long‑term disability worldwide.
Intravenous tissue plasminogen activator (IV rtPA)
is an approved treatment for AIS, though many
patients will not qualify for the treatment because of
the narrow time window for administration of rtPA.
Recently, endovascular treatment with mechanical
thrombectomy has been shown to yield superior
outcomes than pharmacological management alone
for AIS affecting the anterior circulation.[1-5]

local anaesthesia. Multiple studies have compared GA
and CS for the endovascular treatment of AIS and have
reported an association of GA with poor outcomes.[6-14]
In most of these studies, patients who received GA
had a higher pre‑procedural NIHSS score and required
intubation for airway protection. In these studies, GA
was found to be an independent predictor for poor
outcomes even after adjusting for stroke severity,
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The anaesthetic management of patients undergoing
mechanical thrombectomy varies between general
anaesthesia (GA) with or without intubation, conscious
sedation (CS), to completely awake patients under
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though the reasons are not clear. It is speculated that
the variation in the haemodynamic changes occurring
during GA, mainly hypotension and hypocapnia,
might lead to poorer outcomes.[14,15] Based on these
studies, CS has become a popular anaesthetic choice
for mechanical thrombectomy. It is unclear, however,
which factors under CS anaesthesia influence clinical
outcome. The aim of this retrospective study is to
identify these factors.

METHODS
The institutional review board (IRB) approval was
obtained to conduct this retrospective chart review
of patients treated at a single hospital between
January 2009 and June 2015. Patients 18 years old
or older who underwent endovascular treatment
for AIS under CS were included. Patients treated
under GA were excluded. CS with midazolam and
fentanyl titrated to the Richmond Agitation‑Sedation
Scale 0 to −3 was provided by trained nursing
staff in neurointerventional radiology. Mechanical
thrombectomies were done by one of the three
fellowship‑trained interventional neuroradiologists.
Anaesthetic details and the vital signs during the
procedure were collected from the paper chart.
Comorbid diseases, medication history, laboratory
parameters and social history were collected from the
electronic medical record. The National Institute of
Health Stroke Scale (NIHSS) score and the modified
Rankin Score (mRS) at discharge were obtained from
a stroke neurology database. Modified treatment in
cerebral ischaemia (mTICI) scores, stroke territory,
devices used for the procedure and post‑procedure
haemorrhagic complications were collected from a
radiology database. NIHSS score was evaluated by
vascular neurology residents and fellows, mTICI score
was evaluated by interventional neuroradiologist and
mRS score was evaluated by stroke nurses certified in
the use of the mRS instrument. The primary outcome
measure is the mRS at discharge. Good outcome is
defined as mRS 0–3 and poor outcome as mRS 4–6.

not normally distributed were represented as median
and interquartile range (IQR). All factors that were
statistically significant (P < 0.05) in the univariate
analysis were entered into a combination of forward
and backward stepwise modelling techniques. The
stepwise procedure in each specification technique
was designed to construct a model that can best explain
the multivariable relationships in the data. At each
modelling step, a factor may be automatically added
or removed based on its contribution to the overall
model fit and its own significance level (P < 0.05). The
final forward and backward models included slightly
different subsets of significant factors. These selected
factors were then combined into a final regression
and rerun to reconcile between the two technical
approaches and presented as the best‑fitting model.
The overall fit of the final model was assessed using
the c‑statistic, measuring the area under the receiver
operating characteristic (ROC) curve and the Hosmer
and Lemeshow test as a measure of goodness of fit.
A model parameter with P < 0.05 was considered
statistically significant.

RESULTS
A total of 102 patients with mean age 67 ± 16 years
were included in the study. Eighty‑eight (86%) of the
patients were affected by anterior circulation stroke.
The median pre‑procedural NIHSS was 17.5 ranging
from (1–36). Overall 21 (21%) patients had good
outcome at discharge. Penumbra, Solitaire, Merci and
Trevo devices were each used at least once during the
study period. Fifty‑five (54%) patients had mechanical
thrombectomy alone without IV rtPA, 37 (36%) received
intravenous tPA and mechanical thrombectomy,
5 (5%) received intra‑arterial tPA, 2 (2%) received
intra‑arterial tPA and mechanical thrombectomy,
2 (2%) received mechanical thrombectomy and
angioplasty and 1 (1%) received intravenous tPA,
mechanical thrombectomy and intra‑arterial tPA.

Statistical analysis
Statistical analysis was performed with the SAS
version 9.4 (SAS Institute, Cary, North Carolina).
The clinical, anaesthetic, haemodynamic and
neurointerventional characteristics of patients with
poor outcome were compared to those patients
with good outcome using univariate statistics,
specifically the Chi‑square test, Fisher exact test and
independent t‑test. Variables which were tested to be

Table 1 shows the clinical and neurointerventional
characteristics for both the groups at discharge.
Twenty (25%) patients in the poor outcome group had
post‑procedure haemorrhagic complications compared
with 0 (0%) in patients with good outcome (P = 0.01).
About 38 (47%) patients with poor outcome had
previous transient ischaemic attack (TIA) compared
to 3 (14%) in patients with good outcome (P = 0.006).
There was no appreciable difference in outcome based
on the type of devices used during the procedure,
comorbid illnesses (hypertension, diabetes mellitus,
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renal insufficiency, congestive heart failure, coronary
artery disease, atrial fibrillation and hyperlipidaemia),
smoking history or use of medications.
Table 2 shows the clinical, neurointerventional,
laboratory and anaesthetic characteristics for both
the groups at discharge. mTICI scoring after the
intervention was lower (P = 0.01) and the NIHSS score
was higher (P ≤ 0.0001) in the poor outcome group
compared to the good outcome group. Average systolic
blood pressure (SBP) and diastolic blood pressure were

significantly different between both the groups, with
higher values in the poor outcome group (P = 0.013,
0.005). There was no difference in outcome based
on age, laboratory parameters [glucose, high‑density
lipoprotein (HDL), low‑density lipoprotein (LDL),
HbA1c and creatinine levels] or the amount of
anaesthetic agent used during the procedure.
Logistic regression was performed to identify
independent factors associated with poor outcome at
discharge [Table 3]. All predictor variables selected

Table 1: Clinical and neurointerventional characteristics by discharge outcome. Categorical variables are represented as
number (percent)

Characteristic
Overall n (%)
Anterior circulation n (%)
88 (86%)
Aspiration device n (%)
29 (28%)
Retriever device n (%)
29 (28%)
Retriever and aspiration device n (%)
33 (32%)
Post‑procedure haemorrhage on CT n (%)
20 (20%)
Hypertension n (%)
77 (75%)
Diabetes n (%)
31 (30%)
Hyperlipidaemia n (%)
46 (45%)
Renal insufficiency n (%)
17 (17%)
CAD/MI n (%)
28 (27%)
Congestive heart failure n (%)
18 (18%)
Cardiomyopathy n (%)
14 (14%)
Atrial fibrillation n (%)
31 (30%)
Previous TIA n (%)
41 (40%)
Smoking n (%)
20 (20%)

Good outcome (mRS 0‑3) (n=21)
21 (100%)
5 (24%)
6 (29%)
6 (29%)
0 (0%)
13 (62%)
6 (29%)
10 (48%)
3 (14%)
6 (29%)
3 (14%)
2 (10%)
6 (29%)
3 (14%)
2 (10%)

Poor outcome (mRS 4‑6) (n=81)
67 (83%)
24 (30%)
23 (28%)
27 (33%)
20 (25%)
64 (79%)
25 (31%)
36 (44%)
14 (17%)
22 (27%)
15 (19%)
12 (15%)
25 (31%)
38 (47%)
18 (22%)

P
0.07
0.59
0.98
0.67
0.01
0.1
0.84
0.79
1.0
0.89
0.75
0.72
0.83
0.006
0.23

P<0.05 is statistically significant. mRS – Modified Rankin scale; CAD – Coronary artery disease; MI – Myocardial infarction; TIA – Transient ischaemic attack

Table 2: Clinical, neurointerventional, laboratory and anaesthetic characteristics by discharge outcome. Normally
distributed continuous variables are represented as mean±standard deviation and others are represented as median/
interquartile range
Characteristic
Age (mean±SD)
mTICI score (median/IQR)
Pre‑procedural NIHSS score (mean±SD)
HbA1c (median/IQR)
Creatinine (median/IQR)
Troponin (median/IQR)
Blood glucose (mean±SD)
Average RASS (mean±SD)
Average FiO2 (mean±SD)
Average SpO2 (mean±SD)
Average SBP (mean±SD)
Average DBP (mean±SD)
Average HR (mean±SD)
Average RR (mean±SD)
Midazolam (mg) (median/IQR)
Fentanyl (mcg) (mean±SD)
LDL (median/IQR)
HDL (mean±SD)

Overall (mean±SD)/
(median/IQR)
66.72±16
3/2‑4
18.26±6.76
6/5.6‑6.5
0.96/.78‑1.17
0.07/0.03‑0.07
138.32±43.56
−1.79±1.57
0.46±0.25
97.89±1.72
140.47±20.14
76.60±13.43
81.73±17.47
17.87±3.88
1/0‑2
105.51±93.42
83/61‑111
45.06±13.74

Good outcome
(mRS 0‑3) (n=21)
68±14
4/3‑4
12.42±5.48
5.9/5.6‑6
1.07/0.74‑1.13
0.03/0.03‑0.07
131.3±52.75
−1.28±0.90
0.35±0.15
97.90±1.57
130.9±17.03
69.47±14.14
74.19±18.46
17.47±4.33
1/.5‑3.5
108.3±104.1
81/73‑102.5
46.4±9.06

Poor outcome
(mRS 4‑6) (n=81)
66±17
3/2‑4
19.8±6.2
6.1/5.7‑6.6
0.95/0.79‑1.2
0.07/0.03‑0.07
140.2±40.89
−1.92±1.68
0.48±0.26
97.88±1.76
143±20.22
78.44±12.68
83.67±16.77
17.97±3.77
0.63/0‑2
104.8±91.14
84/57‑116
44.66±14.85

P

0.62
0.01
<0.0001
0.1
0.97
0.16
0.4
0.02
0.005
0.97
0.013
0.005
0.02
0.6
0.18
0.8
0.62
0.52

P<0.05 is statistically significant. NIHSS – National Institute of Health Stroke Scale; mTICI – modified treatment in cerebral ischaemia; mRS – Modified Rankin
scale; LDL – Low‑density lipoprotein; HDL – High‑density lipoprotein; RASS – Richmond Agitation‑Sedation scale; SBP – Systolic blood pressure; DBP – Diastolic
blood pressure; HR – Heart rate; RR – Respiratory rate; FiO2 – Fraction of inspired oxygen; SpO2 – Oxygen saturation; HbA1c – Glycosylated haemoglobin
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Figure 1: Shows the receiver operating characteristic curve for the predictor variables and the entire model. Area under the curve for the overall
model is 0.8903

Table 3: Final logistic regression analysis for poor
outcome at discharge
Characteristic
mTICI score
NIHSS score
TIA

Odds ratio
0.443
1.290
6.988

95% Confidence interval
0.244‑0.805
1.125‑1.481
1.342‑36.380

P
0.007
0.0003
0.02

P<0.05 is statistically significant mTICI – Modified treatment in cerebral
ischaemia score; NIHSS – National Institute of Health Stroke Scale;
TIA – Transient ischaemic attack

using the stepwise procedure were entered into
the final model as a single step rather than filtering
independent variables based on their final significant
P values. The final multivariable logistic regression
model had a very good discrimination (c‑statistic of
0.89) and a good calibration (Hosmer–Lemeshow test,
Chi‑square = 4.0193, P = 0.8554) with an overall area
under the curve 0.89 [Figure 1]. The mTICI scoring
[odds ratio (OR): 0.443, confidence interval (CI):
0.244–0.805] (P = 0.007), NIHSS score (OR: 1.290,
CI: 1.125–1.481) (P = 0.0003) and TIA (OR: 6.988,
CI: 1.342–36.380) (P = 0.02) were found to be the
significant predictors of poor outcome at discharge.

DISCUSSION
Our study finds that the outcome of the patients at
discharge who underwent endovascular treatment for
AIS under CS is mainly dependent on 1) NIHSS score
at presentation 2) post‑treatment mTICI score and 3) a
history of previous TIA. To the best of our knowledge,
this is the first study which compared the outcomes
under CS for the endovascular treatment of AIS.
Though CS is a recommended choice when feasible
954

for these procedures, GA cannot be avoidable
in certain group of patients such as those with
posterior circulation stroke or those who are highly
uncooperative or agitated.
Studies which compared GA and CS during
endovascular treatment of AIS have favoured CS
based on superior outcomes,[6-14] though a recent
prospective, randomised trial found no difference in
outcomes between the GA and CS groups.[16] Those
studies which did suggest superior outcomes with
CS speculated that the haemodynamic parameters
such as hypocapnia and hypotension may lead to
poor outcomes under GA[14,15] and thus recommend
the maintenance of normocapnia (35–45 mmHg) and
SBP in the range of 140–180 mmHg.[17] In our study,
we found no evidence of difficulty maintaining SBP
in these patients. Indeed, most of these patients were
hypertensive at presentation and several needed
antihypertensive agents to lower intraprocedural SBP.
It is surprising to note that higher blood pressures
were associated with worse outcomes in this study.
This may be related to more severe strokes or lower
recanalisation rates. However, this factor was not
significant in the multivariable analysis.
Excessive mechanical ventilation under GA can result
in hypocapnia, which in turn may lead to cerebral
vasoconstriction and exacerbate poor outcome in the
setting of AIS. It is assumed that patients under CS
with spontaneous ventilation maintain normocapnia,
which might avoid the possibility of cerebral
vasoconstriction and yield better clinical outcomes. In
Indian Journal of Anaesthesia | Volume 62 | Issue 12 | December 2018
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our study, we are not able to determine the effect of CO2
level as arterial lines were not placed for most patients.
Furthermore, end‑tidal CO2 (EtCO2) measurements
from the nasal cannula or the non‑rebreather simple
oxygen mask used during CS are only indicative of
adequate ventilation and do not accurately quantify
CO2.
Our finding of the association of higher NIHSS
score and the poor outcomes in these patients
is not surprising. NIHSS score is known to be a
strong predictor of functional outcome after AIS
[Appendix 1].[18,19] TICI score is the most widely
accepted scale to assess the extent of reperfusion
after the mechanical thrombectomy and has a
proven value for predicting clinical outcome after
AIS [Appendix 2].[20,21] As expected, we found an
association between poor outcome at discharge and
lower mTICI score. Another significant finding in our
study is that previous TIA is independently associated
with poor outcome. The existing literature on this
association is mixed. Some authors have suggested
that a history of TIA confers neuroprotection due
to ischaemic preconditioning, resulting in better
outcomes following AIS in patients with a history of
previous TIA.[22-24] Others, like us, have suggested that
previous TIA leads to poor outcome.[25] Additional
factors such as the subtype of stroke or the duration,
location and timing of previous TIA might influence
the association between these factors.
The overall outcomes in this cohort were worse than
those reported in the recent thrombectomy trials.[26,27]
This is likely related to several factors. Many of these
patients were treated with older generation devices
with lower recanalisation rates. In addition, patient
selection was generally based on the presence of
a large vessel occlusion, onset within 6 h and the
absence of extensive early ischaemic changes on CT.
These inclusion criteria are similar to those used in
MR CLEAN[7] and these outcomes are similar.
Our study has several limitations. First, this is a single
centre retrospective study with associated risk of bias.
Second, sample size is relatively small due to the lack
of widespread adoption of mechanical thrombectomy
prior to the publication of positive trials, and therefore
this study is likely underpowered to eliminate
all clinically important associations between the
anaesthetic factors and the neurologic outcomes.
Third, some data are not universally available or of
desired quality. For example, onset‑to‑reperfusion

time and initial SBP are generally unavailable in
patients transferred from outside hospitals, while
EtCO2 PaCO2 were not measured in all patients, and
intra‑procedural blood pressures were recorded only
every 10 min. Fourth, CS is generally administered
by the neurointerventional team rather than by
anaesthesiologists. Fifth, variations in treatment
methods, including specific device used, may have
influenced outcomes. Sixth, our classification and
analysis of the mRS (0–2) as good outcomes resulted
in a questionable validity of our model because of
smaller sample size. Most clinicians agree that a
mRS 0–2 reflects better the reality of a good outcome.
However, there are other articles which have taken
mRS (0–3) as good outcomes based on the functional
independence [Appendix 3].[28,29] Finally, the method
of patient selection in the early part of the review
period may not reflect current practices. At our
hospital, for instance, thrombectomy was considered
experimental prior to publication of positive
thrombectomy trials and was generally performed
only for profoundly affected patients that did not
qualify for other treatments, which likely skews our
data towards poorer outcomes.
With all the limitations mentioned above, we
conclude that no specific factor regarding CS could
be identified as having a significant effect on the
patient’s outcome. It may be that CS has minimal
physiological effects on the body. Larger multicentre
prospective studies should be conducted in this
area to enlighten the impact of anaesthetics on these
patients.

CONCLUSION
In our study, good outcome in patients undergoing
endovascular treatment for AIS under CS is associated
with higher post‑treatment mTICI score, lower NIHSS
score at presentation and a lack of previous TIA.
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APPENDICES
Appendix 1

NIHSS score – National Institute of Health Stroke Scale score

Appendix 2

mTICI – Modified treatment in cerebral ischaemia score; MCA – Middle
cerebral artery

Appendix 3

mRS – Modified Rankin Scale score
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